Understanding sex biases in immunity: Effects of estrogen on the differentiation and function of antigen-presenting cells

Immunologic Research

Volumn 31, Issue 2, 2005, Pages 91-106

  Nalbandian, Greg ^a   Kovats, Susan ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Antigen presenting cells; Autoimmunity; Dendritic cells; Estrogen; Immunoendocrinology; Sex hormone

Indexed keywords

CD4 ANTIGEN; ESTRADIOL; ESTRIOL; ESTROGEN; ESTROGEN RECEPTOR; ESTRONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; SEX HORMONE; STEROID HORMONE; TAMOXIFEN; TOREMIFENE;

ANTIGEN PRESENTING CELL; AUTOIMMUNITY; B LYMPHOCYTE; CELL DIFFERENTIATION; CELL FUNCTION; CELL POLARITY; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; DENDRITIC CELL; FEMALE; HUMAN; IMMUNITY; INFECTION; INNATE IMMUNITY; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE;

EID: 18244373936     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1385/ir:31:2:091     Document Type: Review

References (131)

1. Liu YJ: Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell 2001;106:259.
2. Mellman I, Steinman RM: Dendritic cells: specialized and regulated antigen processing machines. Cell 2001;106:255.
3. Lanzavecchia A, Sallusto F: The instructive role of dendritic cells on T cell responses: lineages, plasticity and kinetics. Curr Opin Immunol 2001;13:291.
4. Eisenbarth SC, Piggott DA, Bottomly K: The master regulators of allergic inflammation: dendritic cells in Th2 sensitization. Curr Opin Immunol 2003;15:620.
5. Turley SJ: Dendritic cells: inciting and inhibiting autoimmunity. Curr Opin Immunol 2002;14:765.
6. Harding CV, Ramachandra L, Wick MJ: Interaction of bacteria with antigen-presenting cells: influences on antigen presentation and antibacterial immunity. Curr Opin Immunol 2003;15:112.
7. Miller L, Hunt JS: Sex steroid hormones and macrophage function. Life Sci 1996;59:1.
8. Whitacre CC, Reingold SC, O'Looney PA: A gender gap in autoimmunity. Science 1999;283:1277.
9. Olsen NJ, Kovacs WJ: Gonadal steroids and immunity. Endocr Rev 1996;17:369.
10. Ansar Ahmed S, Penhale WJ, Talal N: Sex hormones, immune responses, and autoimmune diseases. Mechanisms of sex hormone action. Am J Pathol 1985;121:531.
11. Olsen NJ, Kovacs WJ: Hormones, pregnancy, and rheumatoid arthritis. J Gend Specif Med 2002;5:28.
12. Kincade PW, Medina KL, Smithson G, Scott DC: Pregnancy: a clue to normal regulation of B lymphopoiesis. Immunol Today 1994;15:539.
13. Sacks G, Sargent I, Redman C: An innate view of human pregnancy. Immunol Today 1999;20:114.
14. Wilder RL: Hormones, pregnancy, and autoimmune diseases. Ann NY Acad Sci 1998;840:45.
15. Bebo BF, Jr., Schuster JC, Vandenbark AA, Offner H: Androgens alter the cytokine profile and reduce encephalitogenicity of myelin-reactive T cells. J Immunol 1999;162:35.
16. Komi J, Lassila O: Nonsteroidal anti-estrogens inhibit the functional differentiation of human monocyte-derived dendritic cells. Blood 2000;95:2875.
17. Whitacre CC: Sex differences in autoimmune disease. Nat Immunol 2001;2:777.
18. Barna M, Komatsu T, Bi Z, Reiss CS: Sex differences in susceptibility to viral infection of the central nervous system. J Neuroimmunol 1996;67:31.
19. Kappel CA, Melvold RW, Kim BS: Influence of sex on susceptibility in the Theiler's murine encephalomyelitis virus model for multiple sclerosis. J Neuroimmunol 1990;29:15.
20. Han X, Lundberg P, Tanamachi B, et al.: Gender influences herpes simplex virus type 1 infection in normal and gamma interferon-mutant mice. J Virol 2001;75:3048.
21. Dalal M, Kim S, Voskuhl RR: Testosterone therapy ameliorates experimental autoimmune encephalomyelitis and induces a T helper 2 bias in the autoantigen-specific T lymphocyte response. J Immunol 1997;159:3.
22. Padgett DA, Loria RM, Sheridan JF: Endocrine regulation of the immune response to influenza virus infection with a metabolite of DHEA-androstenediol. J Neuroimmunol 1997;78:203.
23. Bebo BF, Jr., Fyfe-Johnson A, Adlard K, et al.: Low-dose estrogen therapy ameliorates experimental autoimmune encephalomyelitis in two different inbred mouse strains. J Immunol 2001;166:2080.
24. Kim S, Liva SM, Dalal MA, et al.: Estriol ameliorates autoimmune demyelinating disease: implications for multiple sclerosis. Neurology 1999;52:1230.
25. Nelson JL: Pregnancy immunology and autoimmune disease. J Reprod Med 1998;43:335.
26. Confavreux C, Hutchinson M, Hours MM, et al.: Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. N Engl J Med 1998;339:285.
27. Petri M: Systemic lupus erythematosus and pregnancy. Rheum Dis Clin North Am 1994;20:87.
28. Vernon-Roberts B: The effects of steroid hormones on macrophage activity. Int Rev Cytol 1969;25:131.
29. Nicol T, Bilbey DL, Charles LM, Cordingley JL, Vernon-Roberts B: Oestrogen: the natural stimulant of body defence. J Endocrinol 1964;30:277.
30. Hall JM, Couse JF, Korach KS: The multifaceted mechanisms of estradiol and estrogen receptor signaling. J Biol Chem 2001;276:36869.
31. McDonnell DP, Norris JD: Connections and regulation of the human estrogen receptor. Science 2002;296:1642.
32. Couse JF, Lindzey J, Grandien K, et al.: Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse. Endocrinology 1997;138:4613.
33. Couse JF, Korach KS: Estrogen receptor null mice: what have we learned and where will they lead us? Endocr Rev 1999;20:358.
34. Foster HL, Small JD, Fox JG: Normative biology, immunology and husbandry. Academic Press Inc, Orlando, FL, 1983.
35. Simpson ER, Dowsett M: Aromatase and its inhibitors: significance for breast cancer therapy. Recent Prog Horm Res 2002;57:317.
36. Berthois Y, Katzenellenbogen JA, Katzenellenbogen BS: Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. Proc Natl Acad Sci USA 1986;83:2496.
37. Maoz H, Kaiser N, Halimi M, et al.: The effect of estradiol on human myelomonocytic cells. 1. Enhancement of colony formation. J Reprod Immunol 1985;7:325.
38. Boorman GA, Luster MI, Dean JH, Wilson RE: The effect of adult exposure to diethylstilbestrol in the mouse on macrophage function and numbers. J Reticuloendothel Soc 1980;28:547.
39. Diesselhoff-den Dulk MM, Crofton RW, van Furth R: Origin and kinetics of Kupffer cells during an acute inflammatory response. Immunology 1979;37:7.
40. Hoek A, Allaerts W, Leenen PJ, et al.: Dendritic cells and macrophages in the pituitary and the gonads. Evidence for their role in the fine regulation of the reproductive endocrine response. Eur J Endocrinol 1997; 136:8.
41. Komi J, Mottonen M, Luukkainen R, Lassila O: Non-steroidal anti-oestrogens inhibit the differentiation of synovial macrophages into dendritic cells. Rheumatology (Oxford) 2001;40:185.
42. Inaba K, Inaba M, Romani N, et al.: Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 1992;176:1693.
43. Paharkova-Vatchkova V, Maldonado R, Kovats S: Estrogen preferentially promotes the differentiation of CD11c+ CD11b(intermediate) dendritic cells from bone marrow precursors. J Immunol 2004;172:1426.
44. Thurmond TS, Murante FG, Staples JE, et al.: Role of estrogen receptor alpha in hematopoietic stem cell development and B lymphocyte maturation in the male mouse. Endocrinology 2000;141:2309.
45. Kincade PW, Medina KL, Payne KJ, et al.: Early B-lymphocyte precursors and their regulation by sex steroids. Immunol Rev 2000;175:128.
46. Grimaldi CM, Cleary J, Dagtas AS, et al.: Estrogen alters thresholds for B cell apoptosis and activation. J Clin Invest 2002;109:1625.
47. Medina KL, Strasser A, Kincade PW: Estrogen influences the differentiation, proliferation, and survival of early B-lineage precursors. Blood 2000;95:2059.
48. Medina KL, Garrett KP, Thompson LF, et al.: Identification of very early lymphoid precursors in bone marrow and their regulation by estrogen. Nat Immunol 2001;2:718.
49. Latham KA, Zamora A, Drought H, et al.: Estradiol treatment redirects the isotype of the autoantibody response and prevents the development of autoimmune arthritis. J Immunol 2003;171:5820.
50. Liu HY, Buenafe AC, Matejuk A, et al.: Estrogen inhibition of EAE involves effects on dendritic cell function. J Neurosci Res 2002;70:238.
51. Murphy HS, Sun Q, Murphy BA, et al.: Estradiol upregulates MHCII and enhances antigen presentation by dendritic cells. Abstract presented at Keystone Symposium, Dendritic Cells: Interfaces with Immunobiology and Medicine, Keystone, CO, 2003.
52. Tzortzakaki E, Spilianakis C, Zika E, et al.: Steroid receptor coactivator 1 links the steroid and interferon gamma response pathways. Mol Endocrinol 2003; 17:2509.
53. Hunt JS, Miller L, Platt JS: Hormonal regulation of uterine macrophages. Dev Immunol 1998;6:105.
54. Hunt JS, Manning LS, Mitchell D, et al.: Localization and characterization of macrophages in murine uterus. J Leukoc Biol 1985;38:255.
55. Prabhala RH, Wira CR: Sex hormone and IL-6 regulation of antigen presentation in the female reproductive tract mucosal tissues. J Immunol 1995;155:5566.
56. Wira CR, Rossoll RM: Antigen-presenting cells in the female reproductive tract: influence of the estrous cycle on antigen presentation by uterine epithelial and stromal cells. Endocrinology 1995;136:4526.
57. Kaushic C, Frauendorf E, Rossoll RM, et al.: Influence of the estrous cycle on the presence and distribution of immune cells in the rat reproductive tract. Am J Reprod Immunol 1998;39:209.
58. Wira CR, Roche MA, Rossoll RM: Antigen presentation by vaginal cells: role of TGFbeta as a mediator of estradiol inhibition of antigen presentation. Endocrinology 2002;143:2872.
59. Wira CR, Rossoll RM : Oestradiol regulation of antigen presentation by uterine stromal cells: role of transforming growth factor-beta production by epithelial cells in mediating antigen-presenting cell function. Immunology 2003;109:398.
60. Fahey JV, Prabhala RH, Guyre PM, Wira CR: Antigen-presenting cells in the human female reproductive tract: analysis of antigen presentation in pre- and post-menopausal women. Am J Reprod Immunol 1999; 42:49.
61. Prabhala RH, Fahey JV, Humphrey SL, et al.: Regulation by human uterine cells of PBMC proliferation: influence of the phase of the menstrual cycle and menopause. J Reprod Immunol 1998;40:25.
62. Wira CR, Rossoll RM, Kaushic C: Antigen-presenting cells in the female reproductive tract: influence of estradiol on antigen presentation by vaginal cells. Endocrinology 2000;141:2877.
63. Fox HS, Bond BL, Parslow TG: Estrogen regulates the IFN-gamma promoter. J Immunol 1991;146:4362.
64. Stanberry LR, Spruance SL, Cunningham AL, et al.: Glycoprotein-D-adjuvant vaccine to prevent genital herpes. N Engl J Med 2002;347:1652.
65. Wilcoxen SC, Kirkman E, Dowdell KC, Stohlman SA: Gender-dependent IL-12 secretion by APC is regulated by IL-10. J Immunol 2000;164:6237.
66. Kim S, Voskuhl RR: Decreased IL-12 production underlies the decreased ability of male lymph node cells to induce experimental autoimmune encephalomyelitis. J Immunol 1999;162:5561.
67. Liu JW, Dawson DD, Peters CE, et al.: Estrogen replacement in ovariectomized rats results in physiologically significant levels of circulating progesterone, and co-administration of progesterone markedly reduces the circulating estrogen. Endocrine 1997;6:125.
68. Miller L, Hunt JS: Regulation of TNF-alpha production in activated mouse macrophages by progesterone. J Immunol 1998;160:5098.
69. Gilmore W, Weiner LP, Correale J: Effect of estradiol on cytokine secretion by proteolipid protein-specific T cell clones isolated from multiple sclerosis patients and normal control subjects. J Immunol 1997;158:446.
70. Salem ML, Matsuzaki G, Kishihara K, et al.: beta-estradiol suppresses T cell-mediated delayed-type hypersensitivity through suppression of antigen-presenting cell function and Th1 induction. Int Arch Allergy Immunol 2000;121:161.
71. Saito S, Foegh ML, Motomura N, et al.: Estradiol inhibits allograft-inducible major histocompatibility complex class II antigen expression and transplant arteriosclerosis in the absence of immunosuppression. Transplantation 1998;66:1424.
72. Debout C, Lefroit-Joliy M, Neveu T, Izard J: 17 beta estradiol affects the expression of guinea pig blood leukocyte MHC antigens. J Steroid Biochem Mol Biol 1991;38:695.
73. Tabibzadeh SS, Sivarajah A, Carpenter D, et al.: Modulation of HLA-DR expression in epithelial cells by interleukin 1 and estradiol-17 beta. J Clin Endocrinol Metab 1990;71:740.
74. Flynn A: Expression of Ia and the production of interleukin 1 by peritoneal exudate macrophages activated in vivo by steroids. Life Sci 1986;38:2455.
75. Dabrosin C, Palmer K, Gauldie J: Oestradiol enhances tumour regression induced by B7-1/IL-2 adenoviral gene transfer in a murine model of breast cancer. Br J Cancer 2003;89:385.
76. Ito A, Bebo BF, Jr., Matejuk A, et al.: Estrogen treatment down-regulates TNF-alpha production and reduces the severity of experimental autoimmune encephalomyelitis in cytokine knockout mice. J Immunol 2001;167:542.
77. Ito A, Buenafe AC, Matejuk A, et al.: Estrogeninhibits systemic T cell expression of TNF-alpha and recruitment of TNF-alpha(+) T cells and macrophages into the CNS of mice developing experimental encephalomyelitis. Clin Immunol 2002;102:275.
78. Voskuhl RR: Gender issues and multiple sclerosis. Curr Neurol Neurosci Rep 2002;2:277.
79. Kapsenberg ML: Dendritic-cell control of pathogen-driven T-cell polarization. Nat Rev Immunol 2003;3: 984.
80. Matalka KZ: The effect of estradiol, but not progesterone, on the production of cytokines in stimulated whole blood, is concentration-dependent. Neuroendocrinol Lett 2003;24:185.
81. Salem ML, Hossain MS, Nomoto K: Mediation of the immunomodulatory effect of beta-estradiol on inflammatory responses by inhibition of recruitment and activation of inflammatory cells and their gene expression of TNF-alpha and IFN-gamma. Int Arch Allergy Immunol 2000;121:235.
82. Salem ML, Matsuzaki G, Madkour GA, Nomoto K: Beta-estradiol-induced decrease in IL-12 and TNF-alpha expression suppresses macrophage functions in the course of Listeria monocytogenes infection in mice. Int J Immunopharmacol 1999;21:481.
83. Samy TS, Zheng R, Matsutani T, et al.: Mechanism for normal splenic T lymphocyte functions in proestrus females after trauma: enhanced local synthesis of 17beta-estradiol. Am J Physiol Cell Physiol 2003; 285:C139.
84. Bao M, Yang Y, Jun HS, Yoon JW: Molecular mechanisms for gender differences in susceptibility to T cell-mediated autoimmune diabetes in nonobese diabetic mice. J Immunol 2002;168:5369.
85. Angele MK, Knoferl MW, Ayala A, et al.: Testosterone and estrogen differently effect Th1 and Th2 cytokine release following trauma-haemorrhage. Cytokine 2001; 16:22.
86. Fanti P, Nazareth M, Bucelli R, et al.: Estrogen decreases chemokine levels in murine mammary tissue: implications for the regulatory role of MIP-1 alpha and MCP-1/JE in mammary tumor formation. Endocrine 2003;22:161.
87. Kanda N, Watanabe S: 17beta-estradiol inhibits the production of RANTES in human keratinocytes. J Invest Dermatol 2003;120:420.
88. Kanda N, Watanabe S: 17beta-estradiol, progesterone, and dihydrotestosterone suppress the growth of human melanoma by inhibiting interleukin-8 production. J Invest Dermatol 2001;117:274.
89. Yang NN, Venugopalan M, Hardikar S, Glasebrook A: Identification of an estrogen response element activated by metabolites of 17beta-estradiol and raloxifene. Science 1996;273:1222.
90. Yang NN, Bryant HU, Hardikar S, et al.: Estrogen and raloxifene stimulate transforming growth factor-beta 3 gene expression in rat bone: a potential mechanism for estrogen- or raloxifene-mediated bone maintenance. Endocrinology 1996;137:2075.
91. Ruh MF, Bi Y, Cox L, et al.: Effect of environmental estrogens on IL-1beta promoter activity in a macrophage cell line. Endocrine 1998;9:207.
92. An J, Ribeiro RC, Webb P, et al.: Estradiol repression of tumor necrosis factor-alpha transcription requires estrogen receptor activation function-2 and is enhanced by coactivators. Proc Natl Acad Sci USA 1999; 96:15161.
93. Stein B, Yang MX: Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta. Mol Cell Biol 1995;15:4971.
94. Ray A, Prefontaine KE, Ray P: Down-modulation of interleukin-6 gene expression by 17 beta-estradiol in the absence of high affinity DNA binding by the estrogen receptor. J Biol Chem 1994;269:12940.
95. Yamamoto T, Matsuda T, Junicho A, et al.: Cross-talk between signal transducer and activator of transcription 3 and estrogen receptor signaling. FEBS Lett 2000;486:143.
96. Deshpande R, Khalili H, Pergolizzi RG, et al.: Estradiol down-regulates LPS-induced cytokine production and NFκB activation in murine macrophages. Am J Reprod Immunol 1997;38:46.
97. Zhang X, Wang L, Zhang H, et al.: Estrogen inhibits lipopolysaccharide- induced tumor necrosis factor-alpha release from murine macrophages. Methods Find Exp Clin Pharmacol 2001;23:169.
98. Hu SK, Mitcho YL, Rath NC: Effect of estradiol on interleukin 1 synthesis by macrophages. Int J Immunopharmacol 1988;10:247.
99. Chao TC, Van Alten PJ, Greager JA, Walter RJ: Steroid sex hormones regulate the release of tumor necrosis factor by macrophages. Cell Immunol 1995;160:43.
100. Chao TC, Chao HH, Chen MF, et al.: Female sex hormones modulate the function of LPS-treated macrophages. Am J Reprod Immunol 2000;44:310.
101. Holmdahl R, Jansson L, Andersson M: Female sex hormones suppress development of collagen-induced arthritis in mice. Arthritis Rheum 1986;29:1501.
102. Jansson L, Mattsson A, Mattsson R, Holmdahl R: Estrogen induced suppression of collagen arthritis. V: physiological level of estrogen in DBA/1 mice is therapeutic on established arthritis, suppresses anti-type II collagen T-cell dependent immunity and stimulates polyclonal B-cell activity. J Autoimmun 1990;3:257.
103. Hirahara F, Wooley PH, Luthra HS, et al.: Collagen-induced arthritis and pregnancy in mice: the effects of pregnancy on collagen-induced arthritis and the high incidence of infertility in arthritic female mice. Am J Reprod Immunol Microbiol 1986;11:44.
104. Jansson L, Holmdahl R: Enhancement of collagen-induced arthritis in female mice by estrogen receptor blockage. Arthritis Rheum 2001;44:2168.
105. Maret A, Coudert JD, Garidou L, et al.: Estradiol enhances primary antigen-specific CD4 T cell responses and Th1 development in vivo. Essential role of estrogen receptor alpha expression in hematopoietic cells. Eur J Immunol 2003;33:512.
106. Fox CJ, Danska JS: IL-4 expression at the onset of islet inflammation predicts nondestructive insulitis in nonobese diabetic mice. J Immunol 1997;158:2414.
107. McKay LI, Cidlowski JA: Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways. Endocr Rev 1999;20:435.
108. Evans MJ, Eckert A, Lai K, et al.: Reciprocal antagonism between estrogen receptor and NF-kappaB activity in vivo. Circ Res 2001;89:823.
109. Janeway CA, Jr., Medzhitov R: Innate immune recognition. Annu Rev Immunol 2002;20:197.
110. Woltman AM, de Fijter JW, Kamerling SW, et al.: The effect of calcineurin inhibitors and corticosteroids on the differentiation of human dendritic cells. Eur J Immunol 2000;30:1807.
111. Penna G, Adorini L: 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 2000;164:2405.
112. Griffin MD, Lutz W, Phan VA, et al.: Dendritic cell modulation by lalpha,25 dihydroxy vitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc Natl Acad Sci USA 2001;98:6800.
113. Wu L, D'Amico A, Winkel KD, et al.: RelB is essential for the development of myeloid-related CD8alpha-dendritic cells but not of lymphoid-related CD8alpha+ dendritic cells. Immunity 1998;9:839.
114. Burkly L, Hession C, Ogata L, et al.: Expression of relB is required for the development of thymic medulla and dendritic cells. Nature 1995;373:531.
115. Dutertre M, Smith CL: Molecular mechanisms of selective estrogen receptor modulator (SERM) action. J Pharmacol Exp Ther 2000;295:431.
116. Grese TA, Sluka JP, Bryant HU, et al.: Molecular determinants of tissue selectivity in estrogen receptor modulators. Proc Natl Acad Sci USA 1997;94:14105.
117. Onoe Y, Miyaura C, Ito M, et al.: Comparative effects of estrogen and raloxifene on B lymphopoiesis and bone loss induced by sex steroid deficiency in mice. J Bone Miner Res 2000;15:541.
118. Erlandsson MC, Jonsson CA, Lindberg MK, et al.: Raloxifene- and estradiol-mediated effects on uterus, bone and B lymphocytes in mice. J Endocrinol 2002;175:319.
119. Paavonen T, Andersson LC: The oestrogen antagonists, tamoxifen and FC-1157a, display oestrogen like effects on human lymphocyte functions in vitro. Clin Exp Immunol 1985;61:467.
120. Baral E, Blomgren H, Wasserman J, et al.: Effect of tamoxifen on pokeweed mitogen stimulated immunoglobulin secretion in vitro. J Clin Lab Immunol 1986; 21:137.
121. Wu WM, Suen JL, Lin BF, Chiang BL: Tamoxifen alleviates disease severity and decreases double negative T cells in autoimmune MRL-lpr/lpr mice. Immunology 2000;100:110.
122. Valavaara R, Tuominen J, Toivanen A: The immunological status of breast cancer patients during treatment with a new antiestrogen, toremifene. Cancer Immunol Immunother 1990;31:381.
123. Komi J, Lassila O: Antioestrogens enhance tumour necrosis factor receptor 2 (TNF-R2) expression and TNF-R2-mediated proliferation in activated T cells. Scand J Immunol 1998;48:254.
124. Jarvinen LS, Pyrhonen S, Kairemo KJ, Paavonen T: The effect of anti-oestrogens on cytokine production in vitro. Scand J Immunol 1996;44:15.
125. Dayan M, Zinger H, Kalush F, et al.: The beneficial effects of treatment with tamoxifen and anti-oestradiol antibody on experimental systemic lupus erythematosus are associated with cytokine modulations. Immunology 1997;90:101.
126. Colletta AA, Wakefield LM, Howell FV, et al.: Anti-oestrogens induce the secretion of active transforming growth factor beta from human fetal fibroblasts. Br J Cancer 1990;62:405.
127. Erlandsson MC, Gomori E, Taube M, Carlsten H: Effects of raloxifene, a selective estrogen receptor modulator, on thymus, T cell reactivity, and inflammation in mice. Cell Immunol 2000;205:103.
128. Yotsumoto S, Shimomai K, Hashiguchi T, et al.: Estrogen dermatitis: a dendritic-cell-mediated allergic condition. Dermatology 2003;207:265.
129. Homo-Delarche F, Fitzpatrick F, Christeff N, et al.: Sex steroids, glucocorticoids, stress and autoimmunity. J Steroid Biochem Mol Biol 1991;40:619.
130. Wilder RL: Neuroendocrine-immune system interactions and autoimmunity. Annu Rev Immunol 1995; 13:307.
131. McEwen BS, Biron CA, Brunson KW, et al.: The role of adrenocorticoids as modulators of immune function in health and disease: neural, endocrine and immune interactions. Brain Res Brain Res Rev 1997; 23:79.